Last reviewed · How we verify
Dipexium Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Topical pexiganan cream 0.8% | Topical pexiganan cream 0.8% | phase 3 | Antimicrobial peptide | Bacterial cell membrane | Infectious Disease / Dermatology |
Therapeutic area mix
- Infectious Disease / Dermatology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Abeona Therapeutics, Inc · 1 shared drug class
- Guangzhou Yipinhong Pharmaceutical CO.,LTD · 1 shared drug class
- Maruho Co., Ltd. · 1 shared drug class
- Tufts Medical Center · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Dipexium Pharmaceuticals, Inc.:
- Dipexium Pharmaceuticals, Inc. pipeline updates — RSS
- Dipexium Pharmaceuticals, Inc. pipeline updates — Atom
- Dipexium Pharmaceuticals, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Dipexium Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dipexium-pharmaceuticals-inc. Accessed 2026-05-16.